Skip to the page

Data / Drug companies / I World Pharmaceutical Co., Ltd.

I World Pharmaceutical Co., Ltd.: 6 products in the FDA NDC directory, labeler code 73442

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

I World Pharmaceutical Co., Ltd. (labeler code 73442) lists 6 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 6 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on September 16, 2020.

The request: Watch I World Pharmaceutical Co., Ltd. (FDA labeler code 73442): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
73442
Products in commercial distribution
6
Packages
6
Finished drugs by generic name
4
Prescription products
0
Over the counter products
6
Flagged as original packager
6 of 6 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
October 8, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Other unapproved drugs6100%

Products by type

TypeProductsShare
Over the counter drugs6100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Ssanghwa extract11
Jujube, acetaminophen, chlorheniramine maleate11
Lonicera flower, acetaminophen, dextromethorphan hydromide11
Galgeun-tang extract11

Dosage forms

Dosage formProductsShare
Granule466.7%
Liquid233.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
PEDOXAN Extract73442-0014GranuleOther unapproved drugsSeptember 16, 2020
JEGAMSAN Extract73442-0013GranuleOther unapproved drugsSeptember 16, 2020
SoCheongRyong Tang Extract73442-0012GranuleOther unapproved drugsSeptember 16, 2020
MaekMunDong Tang Extract73442-0011GranuleOther unapproved drugsSeptember 16, 2020
Ssanggi tang73442-0009LiquidOther unapproved drugsOctober 8, 2019
Ssangbi tang73442-0008LiquidOther unapproved drugsOctober 8, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.